论文部分内容阅读
目的:观察重组人表皮生长因子、磺胺嘧啶锌软膏、湿润烧伤膏3联换药治疗糖尿病足溃疡的疗效。方法:将52例糖尿病足患者随机分为2组,治疗组采用重组人表皮生长因子,磺胺嘧啶锌软膏及湿润烧伤膏涂抹包扎,对照组采用碘伏纱布湿敷包扎,观察总有效率和换药次数。结果:治疗组创面愈合总有效率高于对照组,且换药次数少于对照组。结论:采用3联外用药物治疗糖尿病足溃疡创面可促进创面愈合,缩短治疗时间,减少换药次数,提高治愈率,减少患者经济负担。
Objective: To observe the effect of recombinant human epidermal growth factor, sulfadiazine zinc ointment and MEBO 3 combined dressing in the treatment of diabetic foot ulcer. Methods: Fifty-two patients with diabetic foot were randomly divided into two groups. The treatment group was treated with recombinant human epidermal growth factor, sulfadiazine zinc ointment and MEBO. The control group was treated with iodoform gauze wet dressing and the total effective rate The number of drugs. Results: The total effective rate of wound healing in the treatment group was higher than that in the control group, and the frequency of dressing change was less than that of the control group. Conclusion: The treatment of diabetic foot ulcer wounds with 3 combined external drugs can promote wound healing, shorten the treatment time, reduce the number of dressing changes, improve the cure rate and reduce the economic burden of patients.